[4]  Blue Cross Blue Shield.  Epidermal Growth Factor Receptor Mutations and Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer.  http://www.bcbs.com/blueresources/tec/press/epidermal-growth-factor.html. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.